With Northway Biotech’s expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and…
Browsing: Pharma
As the world embraces the next wave of digital transformation, the Philippines stands at the forefront of revolutionizing its healthcare…
The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders…
ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator Biotech startups often encounter administrative roadblocks on their…
People often associate the end of the year as a time to wind down, slow down and get into the…
Everest Medicines (HKG 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization…
Millions to join “World Meditates with Gurudev” on December 21, 9:30 AM EST / 2:30 GMT / 10:30 PM SGT…
– Officially Benefiting Mainland China Patients Everest Medicines (HKEX 1952.HK, Everest, or the Company), a biopharmaceutical company focused on the discovery,…
– by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis Everest…
On the evening of 10 December, Fosun Tourism Group (FTG) announced on the Hong Kong Stock Exchange its plan to…
Officially Beginning to Benefit Asian Patients Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the…
As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a…
How much sugar does a Singaporean typically take in a day? In a recent speech by Health Minister Mr. Ong Ye Kung, Singapore…
Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical…
Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization…
Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed a Phase I clinical trial on…
Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism…
Significantly Boosting Market Penetration and Driving Valuation Reassessment On November 28, the National Healthcare Security Administration (NHSA) and the Ministry…
Starting A New Chapter in Healthcare Industry Development Kingworld Medicines Group Limited (Kingworld Medicines or the Group, HKG: 1110), a…
Fosun’s creditworthiness has notably improved and gained market recognition On 21 November 2024, S&P Global Ratings released an updated report…